These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21956693)

  • 1. CD22 serves as a receptor for soluble IgM.
    Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
    Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic glycan ligand excludes CD22 from antigen receptor-containing lipid rafts.
    Yu J; Sawada T; Adachi T; Gao X; Takematsu H; Kozutsumi Y; Ishida H; Kiso M; Tsubata T
    Biochem Biophys Res Commun; 2007 Sep; 360(4):759-64. PubMed ID: 17631277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
    Tedder TF; Poe JC; Haas KM
    Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
    Chaouchi N; Vazquez A; Galanaud P; Leprince C
    J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
    Toda M; Akita K; Inoue M; Taketani S; Nakada H
    Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
    J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
    Toda M; Hisano R; Yurugi H; Akita K; Maruyama K; Inoue M; Adachi T; Tsubata T; Nakada H
    Biochem J; 2009 Feb; 417(3):673-83. PubMed ID: 18925876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
    Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
    Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
    Dickler HB; Kubicek MT; Finkelman FD
    J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.
    Nitschke L; Lajaunias F; Moll T; Ho L; Martinez-Soria E; Kikuchi S; Santiago-Raber ML; Dix C; Parkhouse RM; Izui S
    Int Immunol; 2006 Jan; 18(1):59-68. PubMed ID: 16291654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD22 associates with the human surface IgM-B-cell antigen receptor complex.
    Leprince C; Draves KE; Geahlen RL; Ledbetter JA; Clark EA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3236-40. PubMed ID: 8475064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
    Wakabayashi C; Adachi T; Wienands J; Tsubata T
    Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
    Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
    Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Linked Glycosylation Regulates CD22 Organization and Function.
    Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
    Front Immunol; 2019; 10():699. PubMed ID: 31019513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.